A B S T R A C T Blood-brain barrier permeabilitv studies made in man using the indicator dilution method revealed that the extraction of the test substance increases during the upslope of the venous (outflow) dilution curve. The present study aimed to obviate the possibility that this could result from intravascular phenomena, such as interlaminar diffusion (the result of differences in molecular size) and erythrocyte carriage. Several reference substances were employed for the determination of the extraction in order that careful correction could be made for differences in intravascular behavior of the test and reference substance. The test substances studied were D-glucose, L-phenylalanine, water, propranolol, and benzodiazepines, representing both carrier-transported and lipophilic substances. In-diethylenetriamine pentaacetic acid, Na+, C1-, L-glucose, and L-lysine were employed as reference substances.
INTRODUCTION
The indicator dilution method (1) has been widely used for the quantitative determination of capillary permeability and adapted for studies of the blood-brain barrier in man (2) (3) (4) . We are using this method in a Received for publication 5 April 1979 and in revised form 19 December 1979. number of ongoing ivestigations (such as the effect of insulin on the cerebral uptake of glucose) and we have observed some basic features ofthe dilution and extraction curves indicating heterogeneity of the cerebral microcirculation. These aspects will be the subject of this paper.
The method consists of a rapid injection into the internal carotid artery of test and reference substances, followed by collection of blood samples from the internal jugular vein for determination ofthe dilution curves and calculation of the extraction (loss to brain tissue) of the test substance.
Ideally, the test substance and the intravascular reference substance should have the same intravascular behavior with regard to diffusion and erythrocyte carriage. When that is the case, the fractional loss (the extraction [El)1 of the test substance can be calculated in each venous sample. Generally, however, this ideal requirement cannot be met and corrections must be applied to compensate for differences in intravascular behavior.
The theorv of the method is based on a single capillary model; the assumption is made that the capillary bed studied is homogenous. Accordingly, tracer particles with short transit times should pass capillaries with the same flow rates, lengths, and permeabilities as tracer particles with long transit times. With this assumption, it is only necessary to use the upslope of the outflow curves for calculation of the average E; the downslope, which is influenced by backdiffusion oftest substance, can be disregarded.
In our investigations, we observed that the E of glucose increases with time, making estimation of the average E difficult (Fig. 1) . With other test substances we found a similar increase of E during the upslope 'Abbreviations used in this paper: CBF, cerebral blood flow; DTPA, diethylenetriamine pentaacetic acid; E, extraction; t, time. Peak FIGURE 1 E curves for glucose from four (lifferent subjects illustrating the steep increase in E (and the difficulty in assessing a true average E).
of the tracer dilution curves; this seems to indicate heterogeneity of the microcirculation in the human brain. However, to obviate the possible influence of intravascular phenomena on the shape of the E curve, it was necessary to apply corrections for the differences in intravascular behavior of the test and reference molecules. These corrections, which are detailed in this paper, show that the increase in E during the upslope of the dilution curve is not the result of intravascular phenomena, but is likely to be the result of capillarv heterogeneity. The implications of these findings for the calculation of the average E are discussed.
METHODS
Informed consent having been obtained, 42 patients hospitalized for various cerebral disorders requiring carotid angiograms were studied in connection with the angiography. Patients with major cerebral lesions (e.g., larger tutnors) that might interfere with blood-brain barrier functioni were excluded.
Using the Seldinger technique, percutaneous punctures in the neck made under local anaesthesia, a small polyethylene catheter (external diameter 1.7 mm) was introduced into one of the internal jugular veins and a second catheter (external diameter 1.2 mm) introduced into the internal carotid artery on the side appropriate for the angiogram. The tip of the venous catheter was placed in the superior bulb ofthe internal jugular vein; the tip of the arterial catheter was placed in the internal carotid artery just below the siphon. Correct positioning of the arterial catheter was verified by noting the absence of diffuse facial discoloration after a rapid injection of saline or Evans blue. At the end of the study, which usually lasted 20-30 min, the carotid catheter was used for the diagnostic angiogram.
For each determination of blood-brain barrier permeability using the indicator dilution method, a 2-4-ml bolus, containing a test compound and several intravascular reference compounds, was injected rapidly (1-2 s) through the indwelling intracarotid catheter. Starting a few seconds before the injection, a continuous series of 1.0-ml blood samples was collected from the venous catheter by means of a sampling machine and then deposited into dry heparinized tubes at a speed of 1 sample/s. A standard solution was prepared from each bolus by adding an aliquot of injectate to venous blood sampled in a dry heparinized tube before the injection. When repeated studies of the blood-brain barrier were performed, a time interval of 10 min was allowed between measurements.
All isotopes were counted in the plasma of the blood samples, the y-and 8-emitters being counted in the same sample. 24Na+ and I3mIn were counted in a crystal scintillation counter (Packard autogamma 5385, Packard Instrument Co., Inc., Downers Grove, Ill.), appropriate corrections for channel spillover and decay applied. After decay of the y-emitters, 36C1, 3H, and 14C were assayed using liquid scintillation counting (scintillation fluid: Instagel, spectrometer; Packard Tricarb 3375) and corrections for quenching and channel spillover were applied using the method of external standardization.
The cerebral blood flow (CBF) was measured during each study using the 133Xe intra-arterial injection method; 3-4 mCi of '33Xe dissolved in 2-3 ml of isotonic saline were injected rapidly (1-2 s) into the internal carotid artery through the indwelling catheter. The clearance of the isotope from the hemisphere was followed by an externally positioned array of 16 small scintillation detectors; the average hemispheric blood flow was calculated from the initial slope of the semilogarithmicallv recorded clearance curves (5) . Using a conventional electrode, the arterial carbon dioxide tension was determined concomitant with each CBF measurement.
Calculations. At any time (t) of the tracer dilution curve, the E of the test substance can be calculated as:
where Cre,(t) and Ctest(t) are the relative concentrations of the reference and test substance (i.e., counting rate in blood sample divided by counting rate in the standard) corresponding to t. E(t) would represent the true unidirectional fractional transcapillary escape of the test molecule if no intravascular separation oftest and reference substance occurred and if only insignificant backdiffusion took place. Backdiffusion is more pronounced if E is high, especially during the later part of the venous outflow curves. In the present study, no corrections for backdiffusion were applied because we were mainly interested in the shape of the first part of the E(t) curve. Furthermore, backdiffusion would result in a decrease of E(t) with t, whereas we observed the opposite. Intravascular separation (interlaminar diffusion and erythrocyte carriage) of the test and reference substances is an important phenomenon that influences the shape of the E(t) curves (2) (3) (4) 6 ); this in turn influences the calculation of the average E considerably. In previous publications we mini-mized the influence of intravascular separation by using test and reference substances with closely matching intravascular properties and then calculating the average E by integrating a region of the outflow curves appropriate to test-reference substances used. To obtain a more accurate reference curve for each test substance, additional corrections for intravascular separation have now been applied. This involves the simultaneous use of multiple intravascular reference substances and permits correction for both interlaminar diffusion and erythrocyte carriage. The principles of interlaminar diffusion, erythrocyte transport, and the corrections used for a more precise analysis of E(t) curves will be described below.
Interlaminar diffusion (7) is the result of differences in the diffusibility of the test and reference substance, and results in two crossover points on the dilution curves and a U-shaped E(t) curve (8) (Fig. 2) . 24Na+ diffuses more rapidly than '13mIn-DTPA away from the fast-moving axial part of the blood stream into the more slow-moving peripheral parts. Thus, on the upslope, the 24Na+ curve lies below that of ll3mIn-DTPA, and E(t) is positive. On the first part of the downslope the 24Na+ curve lies above that of ll3mIn-DTPA, and E(t) is negative because diffusion of labeled sodium is now reversed, i.e., away from the slow-moving peripheral part of the blood stream into the fast-moving axial part. Later, when the slow-moving peripheral part of the blood stream reaches the venous outflow, 24Na+ has been washed out with the axial blood stream, the 24Na+ curve again lies below that of 113mln-DTPA, and E(t) is positive. When comparing albumin (50,000 Mr) and Na+ (24 Al,), Taylor diffusion is constantly observed (5, 8) . The difference in diffusibility between In-DTPA (506 Mr) and Na+ is, however, much smaller, and interlaminar diffusion is both less pronounced and less evident (in 28 of 41 investigations in the present study, two distinct crossovers between In-DTPA and Na+ curves were observed).
To correct for interlaminar diffusion we used the lI3mIn -DTPA -24Na difference, which in the case of glucose was multiplied by 0.5 because the molecular weight of glucose (180) is halfway between that of Na+ and In-DTPA.
Errjthrocyte carriage (precession). A tracer that penetrates
into the erythrocytes has a shorter transit time than a pure plasma tracer because the transit time of erythrocytes through the cerebral vascular bed is shorter than that of plasma (9) . This is illustrated by comparing36C1-with 24Na+, both ofwhich were used as intravascular reference substances in the present study. 36Cl-penetrates the erythrocytes extremely rapidly (t412 -30 ms) (10), whereas 24Na+ essentially remains in plasma (t412 several hours). The molecular weights are 36 and 24, respectively, and Taylor diffusion is thus negligible. The outflow curves in Fig. 3 demonstrate that the 36C1-curve lies above that of 24Na+ on the upslope, resulting in a negative E(t). The curves then cross near the peak so that during the downslope the 36C1-curve is below that of 24Na+, and E(t) is positive. This curve configuration is invariably present and was found in 38 of 41 investigations.
The difference between the 36Cl-and 24Na+ curves was used to correct for erythrocyte transport. However, the equilibrium distribution between plasma and erythrocytes of the various tracers has to be taken into consideration. For 36Cl-, the Gibbs-Donnan effect will maintain a concentration 30% lower in the erythrocyte water phase than in the plasma water phase (11) . Thus, in whole blood (at normal hematocrit), 25% of36Cl-will be in the erythrocytes. In contrast, D-glucose distributes equally in plasma and erythrocyte water phases, -35% being carried in the erythrocytes, i.e., 50% more than for chloride. Thus, for glucose, the 36C1--24Na+ difference multiplied by 0.5 was added to the 36C1-reference curve to correct for the surplus erythrocyte carriage of glucose.
Corrections of reference curves. The corrections were based on the simultaneous determination of dilution curves for all the test and reference substances involved. In the illustrations (Figs. 4 and 5) , the noncorrected as well as corrected reference curves are given, and it is apparent that corrections are small.
HOH has a molecular size corresponding to that of Cl-(no Taylor correction) and distributes equally in plasma and erythrocyte water so that the carriage of HOH is 50% more than that of Cl-. Thus, by adding 50% of Cl--Na+ difference to the Cl-curve, Cl-was used as the reference after correcting for the difference in erythrocyte carriage. Corrected Cl-= Cl-+ '2(Cl--Na+).
For D-glucose, two different reference substances were used: Cl-and L-glucose. Relative to the transit time, it was assumed that Dglucose penetrates erythrocytes very quickly through the cerebral circulation and, therefore, erythrocyte carriage does not interfere with the estimation ofblood-brain barrier permeability, a problem discussed in detail by Perl (12) and Goresky et al. (13) . No relevant data on the permeability of human erythrocyte to glucose are available but the following data confirm the validity ofthe assumption. Double determinations of mean transit t for glucose and Cl-were made in five patients, both with an injectate of the isotopes in saline and then with the isotopes in a preequilibrated erythrocyte bolus. No significant differences in t were observed: with the saline bolus, t for glucose was 0.07 s (mean) quicker than that for Cl-; with the preequilibrated erythrocyte bolus, glucose t was 0.04 s (mean) slower. In comparison, the difference between mean transit t for erythrocytes and plasma is 1.1 s (9) . The curve configuration and glucose E were also similar in the two situations.
(a) Cl-used as reference, corrected for difference in Taylor diffusion and difference in precession: the molecular size of D-glucose is about halfway between Na+ and In-DTPA. The In-DTPA -Na+ difference multiplied by 0.5 was used to correct for Taylor diffusion vs. Cl-. The correction for difference in precession is analogous to that used for HOH. Corrected Cl-= Cl-+ V2(In-DTPA -Na+) + '/2(Cl--Na+).
(b) L-glucose used as reference, corrected for total difference in precession: L-glucose remains in plasma and there is no erythrocyte carriage, in contrast to 25% for Cl-and 35% for 1-glucose. Thus, when L-glucose was used as the reference substance, the Cl-carriage multiplied by 1.5 was added to L-glucose to correct for the lack of erythrocyte carriage. Because molecular sizes are the same for L-and D-glucose, no correction for the Taylor effect was required. Corrected L-glucose = L-glucose + 1'/2(Cl--Na+).
L-phenylalanine was compared with the reference substance L-lysine. Corrections were unnecessary because they have similar molecular size; both remain in the plasma during transit through the cerebral vascular bed.
Benzodiazepines and propranolol (molecular weights close to 300) have a high cerebral uptake, are lipid soluble, and, VENOUS OUTFLOW CURVES * The suffix to E indicates the percent saturation or desaturation, respectively, of the cotracer curve, 100 being the peak of the curve, e.g., E25 means the E at a point corresponding to 25% saturation of the cotracer on the upslope of the dilution curve, and Ed25 the corresponding value on the downslope.
therefore, can be assumed to penetrate erythrocytes easily. A correction for difference in erythrocyte carriage was, therefore, added to In-DPTA (in an analogous manner to D-glucose vs. L-glucose). To some extent they are protein bound in blood but, because an exact estimate of the degree of binding was not possible in these experiments, we did not attempt an exact Taylor correction but used In-DTPA as the reference molecule. In any case, with these highly extracted substances, a correction for Taylor diffusion would have been small. Corrected In-DTPA = In-DTPA + lY2(Cl--Na+). Minimal E of reference substances with small molecular size often occurs and is probably the result of those areas without a blood-brain barrier (choroid plexus, area postrema, median eminence, pineal body). For L-glucose, L-lysine, Na+, and C1-, the E are 1.5-2.0% (personal observation). Thus, when these were used, a correction was made by adding 2% to the amount of reference in each individual sample. For In-DTPA, such loss to brain tissue is insignificant.
RESULTS
For all of the seven compounds tested, the extraction increased during the upslope of the tracer dilution curves (Table I) .
The slope of the E curves was analyzed by means of linear regression. When all the data for glucose vs. Cl-was considered, the increase was not significant although, when one experiment with a negative slope was omitted, significance was achieved (P < 0.05). For glucose vs. L-glucose, phenylalanine, nitrazepamclonazepam, propranolol, and HOH, the increase was significant (P < 0.05) for each group; in the case of diazepam, the individual curves also rose significantly (P < 0.05). The relative increase in E was of the same order of magnitude for all substances studied, E(t) being -90% of its maximum value at a point on the upslope of the reference curve corresponding to 25% of its peak.
Representative dilution and E curves for glucose and propranolol are illustrated in Figs. 4 and 5, respectively. The corrections for intravascular phenomena only have a minor influence on the shape of the E curves, especially with such highly extracted substances as propranolol.
In an additional group of four patients, the E curve for propranolol was evaluated during normal CBF as well as during low CBF (induced by voluntary hyperventilation) and high CBF (induced by carbon dioxide inhalation) (Table II) . The flow changes had no significant influence on the shape of the E curve.
DISCUSSION
The increase in the E(t) curve during the upslope of the tracer dilution curves cannot be explained by intravascular phenomena. This increase occurred with all the molecules tested, irrespective of transfer condi- * The suffix to E indicates the percent saturation or desaturation, respectively, of the cotracer curve, 100 being the peak of the curve, e.g., E25 means E at a point corresponding to 25% saturation of the cotracer on the upslope of the venous outflow curve, and Ed25 the corresponding value on the downslope.
tions. Thus, it was present for glucose and amino acids, which are transferred by specific carrier mechanisms, as well as for lipophilic substances and water, which enter the brain by dissolving in the plasma membrane phase.
A possible explanation of the increasing E might be that the test substances bypass the capillaries by diffusion from arteries to veins (shunting), as has been described for 133Xe (14) . However, this seems unlikely because the E(t) curves for HOH and propranolol have almost the same slope even though the free diffusion coefficient for HOH is much higher than that for propranolol. Furthermore, the shape ofthe propranolol E curve was not influenced by a CBF decrease, which would have been the case if shunting had been involved. The increasing E must, therefore, be taken as evidence for a certain degree of heterogeneity in the cerebral microcirculation. Thus, tracer particles with short transit t (which correspond to capillaries with high flow rates and/or short lengths) have less contact with the blood-brain barrier and thus a lower extraction than those tracer particles with long transit t. Arteriovenous shunts-if they exist in the human brainmight be included in this phenomenon.
As far as we are aware, no other data on capillary heterogeneity in the brain exist. However, such a heterogeneity is likely because there are differences betwen gray and white matter (15) and perfusion inhomogeneities within the gray matter of the cerebral cortex exist (16) . In vasodilated skeletal muscle, E(t) is constant during the upslope of the tracer dilution curve, indicating that the capillaries are homogenous (17) . Rose and Goresky (18) observed an increase of E(t) during the upslope of the dilution curve for sucrose in the myocardium (albumin was used as reference). However, in contrast to our observations in the brain, the signs of heterogeneity disappeared in the heart at high flow because the E(t) curves flattened out. Their results suggest that capillary intermittency may occur in the vasoconstricted myocardium. It is still not known whether capillary intermittency occurs in brain, but our finding of cerebral capillary perfusion heterogeneity seems to be unrelated to capillary intermittency, the heterogeneity being of a more static nature, uninfluenced by marked CBF changes. It is more likely to be the result of differences in capillary length.
In the following, the implications for the calculation of the average E will be discussed. The presence of cerebral capillary heterogeneity and the differences in intravascular behavior ofthe compounds will influence the calculation of the average E, which is the mean of the weighted values and corresponds to integration of Eq. 1. The difference in intravascular properties can be minimized by choosing test and reference substances with intravascular properties as close to each other as possible. Valid corrections for the remaining small intravascular differences can be made by integrating appropriate parts of the dilution curves as described in previous publications (2) (3) (4) 6) . For substances with low extractions and low backdiffusion, this integration will comprise the upslope and most of the downslope of the curves, e.g., until 40% desaturation for substances with different interlaminar diffusion and until infinity for substances with different erythrocyte transport. When a large part of the curve is integrated in this way, the calculated average E will be a good estimate of the true average E. However, for substances with high E and backdiffusion, the tail part of the outflow curve can be heavily influenced by the backdiffusion and cannot be used for the calculations because the calculated average E would be an underestimation of the true value. Thus, the increase in E(t) as the result of heterogeneity, together with the effect of backdiffusion, could lead to an underestimation of the average E of substances with a high E. In these cases, the best solution is to calculate the average E from a short part of the outflow curves around the peak, and not from the whole upslope, because that would result in a slightly (and spuriously) lower value. Furthermore, the influence of interlaminar diffusion and erythrocyte carriage is also less pronounced around the peak of the venous outflow curves.
In conclusion, our results indicate the presence of capillary perfusion heterogeneity in the human brain. In studies using the indicator dilution method, valid estimates of the average E of test substances can still be obtained if the appropriate part of the venous outflow curves is integrated.
